Psychiatry and Neurology, Neurology · Rochester, NY
NPI
1710191275
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
9
Medicare group memberships
Hospitals
1
Hospital affiliations
601 Elmwood Ave
Rochester, NY, 14642
Phone (585) 275-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
213 services
Medicare patients, 2024
94
Average age 57
Drug cost, 2024
$1.0M
2,080 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas Wychowski was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 53 times for 44 patients. In total Thomas Wychowski billed 213 services in 22 codes, and Medicare paid $14K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 53 | 44 | $10.17 | $539 |
| 99214 Office E&M - Established | Office | 38 | 36 | $66.35 | $2,521 |
| 95720 Neurologic | Facility | 33 | 20 | $155.00 | $5,115 |
| 99215 Office E&M - Established | Office | 22 | 17 | $92.22 | $2,029 |
By year: 2022 $20K for 309 services; 2023 $19K for 304 services; 2024 $14K for 213 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas Wychowski prescribed most often to Medicare patients was Lamotrigine, with 281 prescriptions and refills. In total Thomas Wychowski wrote 2,080 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 281 | 379 | 43 | $5,263 |
| Lacosamide Generic | 223 | 242 | 27 | $23K |
| Levetiracetam Generic | 212 | 334 | 39 | $8,294 |
| Zonisamide Generic | 120 | 166 | 23 | $6,444 |
| Clobazam Generic | 108 | 159 | 27 | $8,474 |
| Vimpat Lacosamide | 107 | 107 | Under 11 | $123K |
| Divalproex Sodium Er Divalproex Sodium | 99 | 104 | 14 | $5,211 |
| Xcopri Cenobamate | 87 | 89 | 14 | $110K |
| Lamotrigine Er Lamotrigine | 64 | 76 | Under 11 | $21K |
| Lamictal Lamotrigine | 50 | 66 | Under 11 | $67K |
| Lamictal Xr Lamotrigine | 49 | 49 | Under 11 | $102K |
| Clonazepam Generic | 47 | 69 | 13 | $824 |
| Topiramate Generic | 44 | 58 | Under 11 | $793 |
| Divalproex Sodium Generic | 42 | 46 | Under 11 | $5,339 |
| Levetiracetam Er Levetiracetam | 40 | 56 | Under 11 | $4,510 |
Brand drugs: 518 claims; generic drugs: 1,543 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas Wychowski $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.